Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-05 · accession 0001765581-23-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-07 | 2023-06-05 | JAZZ | Sablich Kim | EVP, GM of U.S | D - Sale to Iss | $129.73 | -2,082 | 28.5K | -7% | -$270.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-06-05 | D | D | 2,082 | $129.73 | 28,478 | D | — | — |